blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3995490

EP3995490 - CRYSTAL FORM OF BENZIMIDAZOLE-2-ONE COMPOUND, SOLVATE THEREOF, CRYSTAL FORM OF SOLVATE THEREOF, AND PREPARATION METHOD THEREFOR [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.04.2022
Database last updated on 15.06.2024
FormerThe international publication has been made
Status updated on  15.01.2021
Most recent event   Tooltip18.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Medshine Discovery Inc.
Room 218, No. 9 Gaoxin Road
Jiangbei New District
Nanjing, Jiangsu 210032 / CN
[2022/19]
Inventor(s)01 / LEI, Maoyi
288 Futezhong Road, Pudong New Area
Shanghai 200131 / CN
02 / LUO, Yunfu
288 Futezhong Road, Pudong New Area
Shanghai 200131 / CN
 [2022/19]
Representative(s)De Clercq & Partners
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
[2022/19]
Application number, filing date20835633.703.07.2020
[2022/19]
WO2020CN100129
Priority number, dateCN20191060248904.07.2019         Original published format: CN201910602489
CN20201042691119.05.2020         Original published format: CN202010426911
[2022/19]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021000934
Date:07.01.2021
Language:ZH
[2021/01]
Type: A1 Application with search report 
No.:EP3995490
Date:11.05.2022
Language:EN
[2022/19]
Search report(s)International search report - published on:CN07.01.2021
(Supplementary) European search report - dispatched on:EP06.07.2023
ClassificationIPC:C07D209/48, C07D235/26, A61K31/4184, A61P29/00, A61P37/00
[2022/19]
CPC:
A61P29/00 (EP); C07D235/26 (EP,US); A61K31/4184 (EP);
A61P37/00 (EP); C07B2200/13 (US); Y02A50/30 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/19]
TitleGerman:KRISTALLFORM EINER BENZIMIDAZOL-2-ON-VERBINDUNG, DEREN SOLVAT, KRISTALLFORM ODER SOLVAT DAVON UND VERFAHREN ZU IHRER HERSTELLUNG[2022/19]
English:CRYSTAL FORM OF BENZIMIDAZOLE-2-ONE COMPOUND, SOLVATE THEREOF, CRYSTAL FORM OF SOLVATE THEREOF, AND PREPARATION METHOD THEREFOR[2022/19]
French:FORME CRISTALLINE DU COMPOSE BENZIMIDAZOLE-2-ONE, SOLVATE DE CE DERNIER, FORME CRISTALLINE DU SOLVATE DE CELUI-CI ET SON PROCÉDÉ DE PRÉPARATION[2022/19]
Entry into regional phase28.01.2022Translation filed 
28.01.2022National basic fee paid 
28.01.2022Search fee paid 
28.01.2022Designation fee(s) paid 
28.01.2022Examination fee paid 
Examination procedure28.01.2022Examination requested  [2022/19]
20.10.2023Amendment by applicant (claims and/or description)
20.10.2023Date on which the examining division has become responsible
Fees paidRenewal fee
22.06.2022Renewal fee patent year 03
12.05.2023Renewal fee patent year 04
17.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]EP3502099  (MEDSHINE DISCOVERY INC [CN]) [I] 7-15 * Embodiment 4: WX004 on pages 35-36; paragraph [0051] *;
 [I]  - International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use, "IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Q3C(R6)", ICH HARMONISED GUIDELINE, (20160101), pages 1 - 38, URL: https://database.ich.org/sites/default/files/Q3C-R6_Guideline_ErrorCorrection_2019_0410_0.pdf, (20230622), XP093057033 [I] 15 * pages 6-7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.